Stratagene Announces First Quarter 2006 Earnings Release Date and Conference Call
April 25 2006 - 4:00PM
Business Wire
Stratagene Corporation (Nasdaq:STGN), today announced that it will
release first quarter financial results on Thursday, May 4, 2006
after the market close. The Company will also host a conference
call and webcast on Thursday, May 4, 2006 at 1:30 p.m. Pacific Time
to discuss the Company's first quarter results, outlook for the
remainder of 2006, and current corporate developments. The dial-in
number for the conference call is 800-366-7417 for domestic
participants and 303-262-2191 for international participants. A
taped replay of the conference call will also be available
beginning approximately one hour after the call's conclusion and
will remain available for 7 days. It can be accessed by dialing
800-405-2236 for domestic callers and 303-590-3000 for
international callers, using the passcode 11058663#. To access the
live webcast of the call, go to Stratagene's website at
http://www.stratagene.com and click on the Investors icon. An
archived webcast will also be available at
http://www.stratagene.com. About Stratagene Corporation Stratagene
is a developer, marketer and manufacturer of specialized life
science research and diagnostic products. The Company's life
science research unit supports advances in science by inventing,
manufacturing and distributing products that simplify, accelerate
and improve research. These products are used throughout the
academic, industrial and government research sectors in fields
spanning molecular biology, genomics, proteomics, drug discovery
and toxicology. The Company's diagnostic unit develops and
manufactures products for urinalysis, and high quality automated
instrument and reagent systems that use blood samples to test for
more than 1,000 different allergies and autoimmune disorders. In
addition, by combining its expertise in diagnostics and molecular
biology, as well as its experience with FDA regulatory procedures,
the Company is pursuing opportunities to expand its product
portfolio to include molecular diagnostic kits and instrumentation.
More information is available at www.stratagene.com.
Stratagene (NASDAQ:STGN)
Historical Stock Chart
From May 2024 to Jun 2024
Stratagene (NASDAQ:STGN)
Historical Stock Chart
From Jun 2023 to Jun 2024